Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. colomb. cancerol ; 25(4): 222-225, oct.-dic. 2021. graf
Article in Spanish | LILACS | ID: biblio-1388945

ABSTRACT

Resumen La localización extranodal gastrointestinal del linfoma de Hodgkin comprende el 5% de todos los linfomas. Dentro de este grupo, el linfoma anal primario representa menos del 0,05%, siendo por tanto una entidad extremadamente rara. Por otro lado, los tumores neuroendocrinos son un grupo heterogéneo de neoplasias relativamente poco frecuentes, pero de localización fundamentalmente digestiva. La asociación entre un linfoma de Hodgkin de localización anal y un tumor neuroendocrino intestinal no ha sido descrita previamente en la literatura, pero no es en absoluto raro que los tumores neuroendocrinos puedan coexistir con otro tipo de neoplasias. Los autores presentan el caso infrecuente de presentación de linfoma Hodgkin de localización anal asociado a un tumor neuroendocrino intestinal en una paciente mujer de 74 años, describiéndose la clínica, resultados de pruebas complementarias y tratamiento recibido.


Abstract Extranodal gastrointestinal Hodgkin's lymphoma comprises 5% of all lymphomas. In this group, primary rectal lymphoma represents less than 0.05%; thus, it is an extremely rare entity. On the other hand, neuroendocrine tumors are a heterogeneous group of infrequent neoplasms, mainly of digestive location. The association between a rectal Hodgkin's lymphoma and an intestinal neuroendocrine tumor has not been previously described in the literature, but it is not at all uncommon for neuroendocrine tumors to coexist with other types of neoplasms. The authors present a rare case of rectal Hodgkin's lymphoma associated with an intestinal neuroendocrine tumor in a 74-year-old female patient, describing the symptoms, complementary test results, and treatment.


Subject(s)
Female , Aged , Hodgkin Disease , Neuroendocrine Tumors , Lymphoma , Anal Canal , Therapeutics , Selection of the Waste Treatment Site
2.
Rev. colomb. cancerol ; 22(3): 126-129, jul.-set. 2018. graf
Article in Spanish | LILACS | ID: biblio-1058353

ABSTRACT

Resumen El carcinoma neuroendocrino (CNE) es una entidad infrecuente encontrándose usualmente al diagnóstico en estadios avanzados. El tratamiento suele ser combinado, quirúrgico junto a quimiorradioterapia. Presentamos el caso de una mujer de 73 años estudiada por síndrome constitucional y rectorragias. Tras completar estudios fue diagnosticada de CNE rectal pobremente diferenciado a 5 cm del margen anal con adenopatías mesorrectales. Inicio quimioterapia de inducción con respuesta parcial y se realizó resección anterior de recto ultrabaja con anastomosis primaria e ileostomia en asa derivativa, con histología de CNE de células grandes pT2N0 Mx. Posteriormente recibió quimioterapia adyuvante. El CNE rectal es una neoplasia rara, presente entre la 4o-7o década de la vida y con sintomatología similar al adenocarcinoma colorrectal, siendo un tumor poco diferenciado y muy agresivo. El papel de la neo adyuvancia es fundamental dado que suele ser una enfermedad avanzada al diagnóstico, disminuye el tamaño del tumor primario y permite realizar posteriormente resecciones oncológicas.


Abstract Neuroendocrine carcinoma (NC) is an infrequent pathology that is usually found in the advanced stages. The treatment is surgery, and combined chemotherapy andradiotherapy. A 73-year old woman was being studied for constitutional syndrome and rectal bleeding. After which, she was diagnosed with a poorly differentiated rectal NC, 5 cm from de anal margin with mesorectal lymph nodes. Induction chemotheraphy was started with partial response. A low anterior resection of rectum was performed with primary anastomoses and diverting loop ileostomy. The histology result was a large-cell NC, staged as pT2N0 Mx. She then received adjuvant chemotherapy. Rectal NC is infrequent, and usually presents between the fourth and seventh decade of life. Its symptoms are similar to colorectal adenocarcinoma, but it has a lower grade of differentiation, and is more aggressive. Neoadjuvant treatment is essential as it usually a metastatic disease at diagnosis, and helps to decrease the tumor size, and allows oncological surgery to be performed later.


Subject(s)
Humans , Female , Aged , Rectal Neoplasms , Carcinoma, Neuroendocrine , Rectum
SELECTION OF CITATIONS
SEARCH DETAIL